Vince Martin

Vince Martin

Vince Martin has written investing advice for several years, covering stocks across a range of industries. A former registered representative, Martin saw the dot-com bubble inflate and burst in real time, creating a healthy respect for downside risk. He splits his time between Chicago and rural Wisconsin with his wife and three dogs.

Recent Articles

7 Stocks to Buy for a Dovish Federal Reserve

The Federal Reserve this month cut interest rates to zero. That could be a catalyst for these 7 stocks to buy.

Best ETFs for 2020: The U.S. Global Jets ETF Will Stay Grounded

At the start of the year, the JETS ETF looked like one of the best ETFs for 2020. But a pandemic and hidden risks support a 50% decline.

Chevron Stock Shows Just How Much the World Has Changed

Amid the oil price war, Chevron stock has taken a beating. At the same time, the volatility is rational as it reflects a new paradigm in the global markets.

3 Big Stock Charts for Friday: JD.com, Charter, and Thermo Fisher

Friday's big stock charts feature three large-cap names that have found a bottom — and which could keep rallying, particularly with outside help.

In the Coronavirus Vaccine Race, AIM Stock Isn’t a Likely Winner

AIM stock was a big winner on hopes it could join the response to the coronavirus. But its history suggests those hopes are too optimistic.

Neither the Time nor the Market to Buy Luckin Coffee Stock

LK stock has caught a bounce as investors tiptoe back into the market. But downside risk remains elevated.

3 Big Stock Charts for Thursday: Seagate, Okta, and Pinduoduo

The strong bounce in the last two sessions might not be a bottom. Thursday's big stock charts suggest caution.

Valuation, Not Crisis, Is the Key Risk to Nvidia Stock

Although Nvidia looks promising, and NVDA stock is cheaper than it was before, it's not necessarily cheap. Here's what investors need to consider.

3 Big Stock Charts for Wednesday: Netflix, Luckin Coffee, and CrowdStrike

After a record day on Tuesday, Wednesday's big charts include two big winners on Tuesday — and one interesting loser.

Stop Chasing Coronavirus Plays Like Moderna Stock

Stocks like MRNA stock have soared on hopes they will benefit from the coronavirus pandemic. But history shows few, if any, actually will.